Eisai is to work with US-based translational medicine company Aestus Therapeutics to develop novel treatments for psychiatric disorders. The companies’ …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

